# Forssmann

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/forssmann

- Industry: Medical Devices & Equipment
- Headquarters: Nanjing, China
- Website: www.forssmann-med.com
- Latest round: Angel (Oct 15, 2018)
- Investors on record: 2

## About

Based in China, Forssmann is a medical technology company specializing in advanced imaging and healthcare information solutions, focusing on improving diagnostics and treatment in the medical field.Nanjing Forssmann Medical Technology Co., Ltd. is dedicated to providing innovative medical imaging solutions. Founded in 2014 in Nanjing, China, the company successfully completed its most recent funding round in March 2021, raising RMB 172 million from Bluesail Medical. This funding is part of a series of 3 deals the company has undertaken. Forssmann has maintained consistent operational focus without significant pivots.Nanjing Forssmann Medical Technology Co., Ltd. specializes in advanced medical imaging, diagnostics, and healthcare information technology solutions. The company's flagship products include the F1 and F2 intravascular imaging systems, designed for high-resolution imaging, rapid and accurate diagnostics, and treatment planning. These systems utilize optical coherence tomography (OCT) technology to provide detailed, high-definition images of blood vessels, addressing clinical needs in cardiovascular interventions. Released in recent years, these products serve a diverse clientele, including hospitals and clinics in major markets such as Europe and North America, where they are employed by healthcare professionals to improve patient outcomes in cardiac care.The revenue model for Nanjing Forssmann Medical Technology is structured around direct sales of its high-tech medical imaging systems and associated products. Transactions typically occur through B2B partnerships with hospitals and healthcare providers, where the firm supplies its imaging devices alongside necessary technical support and training services. The pricing structure for these advanced systems is positioned at a premium level, reflecting the innovative technology and capabilities they offer, particularly for their F1 and F2 imaging systems. These products are often purchased outright or may involve service agreements that include ongoing support and maintenance, ensuring continuous functionality and alignment with clinical requirements.In March 2021, Forssmann raised RMB 172 million in strategic investment from Bluesail Medical. The company intends to utilize these funds to design and launch new products that enhance imaging technology capabilities. Plans are in place to expand into European and North American markets, aiming for broader adoption by 2023. Forssmann is focused on developing advanced imaging solutions that align with market needs and improve patient outcomes.

## Funding rounds

- Angel, Oct 15, 2018 — Prosperico Ventures, Tahoe VC

## Investors

- Prosperico Ventures (https://capitalatlas.ai/funds/prosperico-ventures) — Angel
- Tahoe VC — Angel